PMGC Holdings Inc. (NASDAQ:ELAB) Sees Large Decrease in Short Interest

PMGC Holdings Inc. (NASDAQ:ELABGet Free Report) was the target of a significant decline in short interest in April. As of April 30th, there was short interest totaling 236,186 shares, a decline of 43.0% from the April 15th total of 414,506 shares. Currently, 20.4% of the shares of the company are sold short. Based on an average trading volume of 1,987,934 shares, the short-interest ratio is presently 0.1 days.

PMGC Stock Down 9.6%

Shares of NASDAQ:ELAB opened at $1.88 on Tuesday. The company has a market cap of $2.18 million, a price-to-earnings ratio of 0.00 and a beta of -0.27. The firm’s 50-day simple moving average is $3.65 and its 200-day simple moving average is $40.16. The company has a quick ratio of 1.72, a current ratio of 1.74 and a debt-to-equity ratio of 0.01. PMGC has a fifty-two week low of $1.62 and a fifty-two week high of $309.12.

PMGC (NASDAQ:ELABGet Free Report) last issued its earnings results on Thursday, May 14th. The company reported ($11.22) earnings per share for the quarter. The firm had revenue of $0.68 million for the quarter.

PMGC Company Profile

(Get Free Report)

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.

Featured Articles

Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.